Annual report pursuant to Section 13 and 15(d)

12. SEGMENTS (Details)

v3.19.1
12. SEGMENTS (Details) - USD ($)
3 Months Ended 12 Months Ended
Dec. 31, 2018
Sep. 30, 2018
Jun. 30, 2018
Mar. 31, 2018
Dec. 31, 2018
Dec. 31, 2017
Revenues $ 4,056,424 $ 4,230,310 $ 4,656,550 $ 4,042,006 $ 16,985,290 $ 22,760,560
Cost of product revenue 11,142,116 9,164,109 9,645,662 12,242,748 42,194,635 29,164,321
Gross (loss) profit         (25,209,345) (6,403,761)
Loss from operations (16,547,660) (13,791,400) (13,417,381) (16,532,503) (60,288,944) (39,309,996)
Interest and other expense, net (1,490,327) (1,344,085) (1,330,450) (1,289,639) (5,454,501) (4,448,979)
Net loss $ (18,037,987) $ (15,135,485) $ (14,747,831) $ (17,822,142) (65,743,445) (43,758,975)
Capital expenditures         2,095,600 2,676,328
Depreciation and amortization expense         3,446,398 2,692,301
Total assets         88,876,521 108,018,833
ADMA BioManufacturing            
Revenues         6,797,548 10,980,987
Cost of product revenue         35,485,273 21,862,140
Gross (loss) profit         (28,687,725) (10,881,153)
Loss from operations         (45,633,715) (19,801,455)
Interest and other expense, net         (1,077,624) (537,235)
Net loss         (46,711,339) (20,338,690)
Capital expenditures         1,580,684 747,402
Depreciation and amortization expense         2,608,776 2,204,772
Total assets         57,818,051 54,004,696
Plasma Collection Centers [Member]            
Revenues         10,044,908 11,636,739
Cost of product revenue         6,709,362 7,302,181
Gross (loss) profit         3,335,546 4,334,558
Loss from operations         (4,470,073) (2,169,192)
Interest and other expense, net         (967) (6,885)
Net loss         (4,471,040) (2,176,077)
Capital expenditures         514,916 1,913,663
Depreciation and amortization expense         814,768 436,687
Total assets         5,443,032 3,933,673
Corporate [Member]            
Revenues         142,834 142,834
Cost of product revenue         0 0
Gross (loss) profit         142,834 142,834
Loss from operations         (10,185,156) (17,339,349)
Interest and other expense, net         (4,375,910) (3,904,859)
Net loss         (14,561,066) (21,244,208)
Capital expenditures         0 15,263
Depreciation and amortization expense         22,854 50,842
Total assets         $ 25,615,438 $ 50,080,464